Ralph Poole's Weblog
Everyone into the deep clear pool.

MY SITE LINKS






MY BOOKMARKS




ARCHIVES








KNOWLEDGE LINKS






Subscribe to "Ralph Poole's Weblog" in Radio UserLand.

Click to see the XML version of this web page.

Click here to send an email to the editor of this weblog.

 

 

Sunday, November 17, 2002
 

This was a TOP STORY in the Mercury News today

CIA searching out technologies to boost national security
The Central Intelligence Agency has come to stay in an area near you. In 1999, the CIA opened up a venture capital firm, In-Q-Tel, on Sand Hill Road -- the heart of Silicon Valley's venture capital community.

There's a new urgency within the CIA to find technology that makes sense of all the unstructured data floating around on the Internet and elsewhere. The agency can't train analysts quickly enough.


6:25:06 PM   comment []>  

Johanna Woll, who is a consultant at the Cap Gemini Ernst & Young Center for Business Innovation, has helped me understand biotechnology and the firms that participate in this industry.   Johnanna works with Chris Meyer and Stan Davis, both of whom are currently writing a new book on adaptive enterprise and the parallels to the natural world.  Bioinformatics and commercializing drugs are my particular interest because there is a significant information management component of the work which is my expertise.   Finding relevant scientific content for drug development and discovery, and being able to share knowledge quickly can accelerate problem solving.  Adopting the right collaboration and electronic work in process environments are important too, because labs are freqently decentralized.  Teams need to work asynchronously as well as in real time across great distances.

Millenium Pharmaceuticals bought a knowledge management system from a firm called Ingenuity.   Here is how Ingenuity describes their product set:

"Research and development is the key driver of value in the pharmaceutical industry. Most leading pharmaceutical companies spend $3-4B per year in R&D, yet, with the sequencing of the human genome and the proliferation of genome-scale experiments, researchers find themselves faced with an exponentially growing body of knowledge and an inability to leverage it into significant productivity gains.

The task of knowledge management is inadequately handled by current IT solutions and remains one of the greatest unmet needs of the pharmaceutical industry and a significant barrier to scientific progress and value creation.

Ingenuity was founded in 1998 to develop a fully integrated knowledge management capability to enable pharmaceutical and biotechnology researchers to make Better Decisions Faster, thus increasing the likelihood of making novel discoveries and decreasing the time and cost to market.

We have developed a proprietary technology platform, unique ontologies for structuring knowledge specific to the pharmaceutical R&D effort and a world wide operational capability to capture knowledge from proprietary and public domains".


5:07:45 PM   comment []>  

Oct-01   With many Web-based services switching from free to for-a-fee, would you pay for content that you're currently getting for no cost? Please Comment.

Click through to get the answer and see the debate.   These polls are published on Information Today's site.   They are publishers of the following magizines:


9:30:47 AM   comment []>  


Click here to visit the Radio UserLand website. © Copyright 2003 Ralph Poole.
Last update: 4/7/2003; 8:54:36 PM.
This theme is based on the SoundWaves (blue) Manila theme.
November 2002
Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
Oct   Dec


Google

Listed on BlogShares


Blogroll Me!



<
? bostonites # >
>